Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
Safe Harbour Statement under the Private Securities Litigation ReformAct of 1995 : Except for the historical information contained herein thisrelease contains forward-looking statements within the meaning of thePrivate Securities Reform Act of 1995. No forward-looking statement canbe guaranteed and actual results may differ materially from thoseprojected. Bavarian Nordic undertakes no
Date:4/2/2008
"Safe Harbour" Statement under the Private Securities Litigation Reform
Act of 1995": Except for the historical information contained herein, this
release contains "forward-looking statements" within the meaning of the
Private Securities Reform Act of 1995. No "forward-looking statement" can
be guaranteed, and actual results may differ materially from those
projected. Bavarian Nordic undertakes no obligation to publicly update any
"forward-looking statement", whether as a result of new information, future
events, or otherwise. Additional information regarding risks and
uncertainties is set forth in the current Annual Report and in Bavarian
Nordic's periodic reports, if any, which we incorporate by reference.
'/>"/>SOURCE Bavarian Nordic A/S Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones2.
Vista Partners Updates Coverage; Maintains $3.20 Target Price3.
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 20074.
NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update5.
SGX Pharmaceuticals Provides Update on SGX523 Clinical Trials6.
ImaRx Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results7.
ImaRx to Report Corporate Updates and 4Q07 Financial Results8.
LUMEDX Updates Real-Time Patient and Resource Scheduler for Healthcare Systems9.
InfuSystem Holdings Provides Business Update and Comments on Fourth Quarter 2007 Financial Results10.
Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 200811.
Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14